J. Čársky

发表

Resorcylidene aminoguanidine induces antithrombotic action that is not dependent on its antiglycation activity.

P. Kazmierczak, C. Watala, I. Žitňanová, 2009, Vascular pharmacology.

Remodelling of the sarcolemma in diabetic rat hearts: The role of membrane fluidity

I. Waczulíková, A. Ziegelhöffer, J. Styk, 2001, Molecular and Cellular Biochemistry.

Influence of pyridoxylidene aminoguanidine on biomarkers of the oxidative stress and selected metabolic parameters of rats with diabetes mellitus.

J. Muchova, Z. Ďuračková, P. Boz̆ek, 2009, General physiology and biophysics.

Rooibos tea (Aspalathus linearis) partially prevents oxidative stress in streptozotocin-induced diabetic rats.

P. Boor, M. Nakano, P. Boz̆ek, 2006, Physiological research.

Influence of β-Resorcylidene Aminoguanidine on Selected Metabolic Parameters and Antioxidant Status of Rats with Diabetes Mellitus

Z. Ďuračková, P. Boz̆ek, O. Uličná, 2002 .

Influence of beta-resorcylidene aminoguanidine on selected metabolic parameters and antioxidant status of rats with diabetes mellitus.

Z. Ďuračková, P. Boz̆ek, O. Uličná, 2002, Physiological research.

Mechanisms that may be involved in calcium tolerance of the diabetic heart.

A. Breier, I. Waczulíková, A. Ziegelhöffer, 1997 .

Serum levels of advanced glycation end products in poorly metabolically controlled children with diabetes mellitus: relation to HbA1c.

K. Bauerová, V. Jakuš, D. Michalková, 2001, Diabetes, nutrition & metabolism.

Values of markers of early and advanced glycation and lipoxidation in serum proteins of children with diabetes mellitus.

K. Bauerová, V. Jakuš, D. Michalková, 2000, Bratislavske lekarske listy.

Crystal and molecular structure of β-resorcylidene aminoguanidine copper(II) complex

N. Taylor, J. Čársky, K. Onuska, 1996 .

Mechanisms that may be involved in calcium tolerance of the diabetic heart

A. Breier, I. Waczulíková, A. Ziegelhöffer, 2004, Molecular and Cellular Biochemistry.

Impaired erythrocyte transmembrane potential in diabetes mellitus and its possible improvement by resorcylidene aminoguanidine.

M. Bryszewska, I. Waczulíková, O. Uličná, 2000, Bioelectrochemistry.

Alteration of T-state binding properties of naturally glycated hemoglobin, HbA1c.

M. Brunori, M. Castagnola, A. Bellelli, 1988, Journal of molecular biology.

Energy Transfer in Acute Diabetic Rat Hearts

I. Waczulíková, A. Ziegelhöffer, J. Styk, 2002, Annals of the New York Academy of Sciences.

Prevention of processes coupled with free radical formation prevents also the development of calcium-resistance in the diabetic heart.

I. Waczulíková, A. Ziegelhöffer, T. Ravingerová, 1999, Life sciences.

Effects of resorcylidene aminoguanidine (RAG) on selected parameters of isolated rat liver mitochondria.

J. Rysz, D. Malińska, M. Labieniec, 2009, Chemico-biological interactions.

PDFlib PLOP: PDF Linearization, Optimization, Protection Page inserted by evaluation version

I. Waczulíková, A. Ziegelhöffer, J. Styk, 2002 .

Adaptation to Increased Energy Demands due to Augmented Calcium Transients

A. Ziegelhöffer, J. Styk, J. Neckář, 2002 .

Decreased fluidity of isolated erythrocyte membranes in type 1 and type 2 diabetes. The effect of resorcylidene aminoguanidine.

I. Waczulíková, B. Krahulec, L. Šikurová, 2000, General physiology and biophysics.

Antioxidant systems in polymorphonuclear leucocytes of Type 2 diabetes mellitus

I. Garaiová, J. Muchova, Z. Ďuračková, 1999, Diabetic medicine : a journal of the British Diabetic Association.

Effect of pyridoxylidene aminoguanidine on human diploid cells B-HEF-2: in vitro cytotoxicity test and cytogenetic analysis.

J. Vojtaššák, L. Danišovič, M. Blaško, 2006, Toxicology in vitro : an international journal published in association with BIBRA.

Experiences with Mucuna in West Africa

P. Vissoh, V. Manyong, J. Čársky, 1998 .

Fluidising effect of resorcylidene aminoguanidine on sarcolemmal membranes in streptozotocin-diabetic rats: blunted adaptation of diabetic myocardium to Ca2+ overload.

I. Waczulíková, A. Ziegelhöffer, Z. Országhová, 2002, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

In vitro evaluation of the cytotoxicity and genotoxicity of resorcylidene aminoguanidine in human diploid cells B-HNF-1.

I. Waczulíková, J. Vojtaššák, L. Danišovič, 2008, Folia biologica.

Inhibition of nonenzymatic protein glycation and lipid peroxidation by drugs with antioxidant activity.

B. Krahulec, V. Jakuš, J. Čársky, 1999, Life sciences.

Fluidity gradient of erythrocyte membranes in diabetics: the effect of resorcylidene aminoguanidine.

I. Waczulíková, L. Šikurová, J. Čársky, 2002, Bioelectrochemistry.

Resorcylidene aminoguanidine induces antithrombotic action that is not dependent on its antiglycation activity.

I. Žitňanová, Z. Ďuračková, I. Waczulíková, 2009, Vascular pharmacology.

In vitro evaluation of the cytotoxicity and genotoxicity of resorcylidene aminoguanidine in human diploid cells B-HNF-1.

I. Waczulíková, J. Vojtaššák, L. Danišovič, 2008, Folia biologica.